These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3875604)

  • 1. Evaluation of the in-vitro antibacterial activity of Sch 34343.
    Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
    Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():147-54. PubMed ID: 3897168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
    Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
    Jacobus NV; Tally FP; Gorbach SL
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of a new penem FCE 22101.
    Hoban DJ
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Loza E; Morosini MI; Cantón R; Almaraz F; Reig M; Baquero F
    Rev Esp Quimioter; 2003 Jun; 16(2):209-15. PubMed ID: 12973459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of the penem antibiotic Sch 34343 against gram-negative and gram-positive bacteria with special reference to multiresistant strains.
    Kayser FH; Novak J; Strässle A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():137-46. PubMed ID: 3849537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of faropenem, a novel oral penem.
    Woodcock JM; Andrews JM; Brenwald NP; Ashby JP; Wise R
    J Antimicrob Chemother; 1997 Jan; 39(1):35-43. PubMed ID: 9044026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae.
    Mouton RP; Mulders SL; van Gestel MH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():111-7. PubMed ID: 3928576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.